Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Naproxen, a 'specific" antirheumatic drug?].

H Altmann

    Arzneimittel-Forschung
    |February 1, 1975
    PubMed
    Summary

    Naproxen, an anti-inflammatory drug, may treat polyarthritis by inhibiting endonuclease. This enzyme is crucial for viral and mycoplasma DNA integration, potentially causing rheumatoid arthritis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia.

    British journal of haematology·2023
    Same author

    In vivo characterization of progestins with reduced non-genomic activity in vitro.

    Ernst Schering Foundation symposium proceedings·2008
    Same author

    CTF5--a new transcriptional activator of the NFI/CTF family.

    Nucleic acids research·1996
    Same author

    Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators.

    The Journal of biological chemistry·1995
    Same author

    Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation.

    The Journal of biological chemistry·1994
    Same author

    Transcriptional activation of NFI/CTF1 depends on a sequence motif strongly related to the carboxyterminal domain of RNA polymerase II.

    Nucleic acids research·1994

    Area of Science:

    • Pharmacology
    • Molecular Biology
    • Immunology

    Context:

    • Rheumatoid arthritis and polyarthritis are inflammatory conditions with potential infectious etiologies.
    • Slow viruses and mycoplasma are investigated as causative agents.
    • Endonuclease activity is implicated in the integration of pathogen DNA into host cells.

    Purpose:

    • To explore the therapeutic potential of naproxen in treating inflammatory arthritis.
    • To investigate the role of endonuclease inhibition in the mechanism of action of naproxen.
    • To discuss the advantages and disadvantages of targeting endonuclease for anti-inflammatory therapy.

    Summary:

    • Naproxen, a non-steroidal anti-inflammatory drug, inhibits endonuclease activity.
    • This inhibition may underlie its therapeutic effects in polyarthritis.
    • The mechanism involves preventing the integration of viral or mycoplasma DNA, potential causes of rheumatoid arthritis.

    Impact:

    • Provides a novel therapeutic principle for managing inflammatory arthritis.
    • Highlights the potential of targeting host-pathogen DNA interactions.
    • Offers insights into the molecular mechanisms of anti-inflammatory drugs.

    Related Experiment Videos